Healthcare provider profile · identity verified

Simin Torabzadeh, MD

Geriatric Medicine · ORANGE, CA · NPI 1336233600

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	414	107
Amlodipine Besylate	Amlodipine Besylate	392	112
Rosuvastatin Calcium	Rosuvastatin Calcium	338	104
Losartan Potassium	Losartan Potassium	329	91
Atorvastatin Calcium	Atorvastatin Calcium	289	83
Famotidine	Famotidine	219	67
Tamsulosin Hcl	Tamsulosin Hcl	144	34
Omeprazole	Omeprazole	140	47
Metformin Hcl	Metformin Hcl	135	36
Gabapentin	Gabapentin	131	36
Lisinopril	Lisinopril	125	31
Eliquis	Apixaban	120	30
Trazodone Hcl	Trazodone Hcl	120	35
Alendronate Sodium	Alendronate Sodium	119	34
Donepezil Hcl	Donepezil Hcl	114	22
Metoprolol Succinate	Metoprolol Succinate	111	30
Escitalopram Oxalate	Escitalopram Oxalate	110	39
Duloxetine Hcl	Duloxetine Hcl	109	25
Quetiapine Fumarate	Quetiapine Fumarate	98	21
Pantoprazole Sodium	Pantoprazole Sodium	92	25
Finasteride	Finasteride	89	20
Metoprolol Tartrate	Metoprolol Tartrate	88	23
Warfarin Sodium	Warfarin Sodium	81	suppressed
Memantine Hcl	Memantine Hcl	77	14
Sertraline Hcl	Sertraline Hcl	76	19
Azelastine Hcl	Azelastine Hcl	75	31
Pravastatin Sodium	Pravastatin Sodium	70	17
Citalopram Hbr	Citalopram Hydrobromide	64	15
Allopurinol	Allopurinol	63	15
Furosemide	Furosemide	62	25
Mirtazapine	Mirtazapine	62	15
Hydrochlorothiazide	Hydrochlorothiazide	61	15
Carvedilol	Carvedilol	57	18
Albuterol Sulfate Hfa	Albuterol Sulfate	53	28
Benazepril Hcl	Benazepril Hcl	52	14
Synthroid	Levothyroxine Sodium	51	16
Clopidogrel	Clopidogrel Bisulfate	50	13
Memantine Hcl Er	Memantine Hcl	50	suppressed
Diclofenac Sodium	Diclofenac Sodium	49	25
Estradiol	Estradiol	46	21
Fluticasone Propionate	Fluticasone Propionate	43	17
Mounjaro	Tirzepatide	43	suppressed
Potassium Chloride	Potassium Chloride	38	13
Pregabalin	Pregabalin	38	11
Bupropion Xl	Bupropion Hcl	37	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Nystatin	Nystatin	36	20
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Atenolol	Atenolol	35	11
Lovastatin	Lovastatin	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Simvastatin	Simvastatin	30	suppressed
Glipizide	Glipizide	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Linzess	Linaclotide	29	suppressed
Restasis	Cyclosporine	29	suppressed
Rytary	Carbidopa/Levodopa	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	20
Ezetimibe	Ezetimibe	26	suppressed
Fentanyl	Fentanyl	25	suppressed
Vascepa	Icosapent Ethyl	25	suppressed
Meloxicam	Meloxicam	24	suppressed
Paricalcitol	Paricalcitol	24	suppressed
Ciclopirox	Ciclopirox	23	13
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Latanoprost	Latanoprost	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	16
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Lorazepam	Lorazepam	22	13
Digoxin	Digoxin	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	13
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Gemtesa	Vibegron	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Temazepam	Temazepam	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Lactulose	Lactulose	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Triazolam	Triazolam	17	suppressed
Baclofen	Baclofen	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Prednisone	Prednisone	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Trospium Chloride	Trospium Chloride	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Enulose	Lactulose	14	suppressed
Minoxidil	Minoxidil	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Ampicillin Trihydrate	Ampicillin Trihydrate	13	12
Azithromycin	Azithromycin	13	13
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Cephalexin	Cephalexin	12	11
Clonazepam	Clonazepam	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Valsartan	Valsartan	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Droxidopa	Droxidopa	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Procto-Med Hc	Hydrocortisone	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error